article thumbnail

The Data-Driven Future of Drug Development

DrugBank

Computational chemistry and molecular modeling techniques can predict potential drug candidates' binding affinity and pharmacokinetic properties, enabling the selection of the most promising compounds for further development.

article thumbnail

Drug Repurposing: A New Life for Old Drugs

DrugBank

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. These candidates can be broadly classified into two categories: serendipitous discoveries and those identified through targeted research on a drug's MoA.

Drugs 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sygnature Discovery accelerates global growth with major North American acquisition

Sygnature Discovery

This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.

article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

From 2005 to 2008 he carried out a DPhil (PhD) at Oxford on nanomaterials for quantum computation, followed by postdoctoral work on the prediction of crystal structures at University College London. Matthew subsequently put his computational chemistry skills to use in the defence sector.

Drugs 105
article thumbnail

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

The Pharma Data

Dr. Chen Mao , Chairman and CEO of Viva Biotech, shared the market potential for CRO and CDMO companies, as well as the four major trends of the CXO industry. As well as continuously upgrading and optimizing existing 9 major technology platforms, Viva has also invested heavily in the fields of Cryo-EM, Computational Chemistry/Biology, etc.

article thumbnail

The Book of Nimbus

LifeSciVC

The premise at the time was that putting computational chemistry in the primary position for new molecule ideation would upend the drug discovery paradigm. set up a “virtual project team,” leverage Schrödinger scientists to lead computational chemistry, and do all the wet work at CROs. It did just that.

article thumbnail

Women in Stem with Dr Rachel Lagiakos

Drug Target Review

There are very few professions that have the ability to make such a profound impact on human health and though few of us drug hunters will get the privilege to see a drug come to market, it is the promise of what can be that inspires us to try.